These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 3878359)

  • 1. Interactions of formylamino- and methoxy-substituted beta-lactam antibiotics with beta-lactamases.
    Okonogi K; Sugiura A; Kuno M; Ono H; Harada S; Higashide E
    J Antibiot (Tokyo); 1985 Nov; 38(11):1555-63. PubMed ID: 3878359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nature of monocyclic beta-lactam antibiotic Nocardicin A to beta-lactamases.
    Kojo H; Mine Y; Nishida M; Goto S; Kuwahara S
    Microbiol Immunol; 1988; 32(2):119-30. PubMed ID: 3287105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescein-labeled beta-lactamase mutant for high-throughput screening of bacterial beta-lactamases against beta-lactam antibiotics.
    Chan PH; Chan KC; Liu HB; Chung WH; Leung YC; Wong KY
    Anal Chem; 2005 Aug; 77(16):5268-76. PubMed ID: 16097768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ways to overcome cephalosporinase-mediated beta-lactam resistance in Enterobacter cloacae.
    Then RL; Angehrn P
    Chemioterapia; 1985 Feb; 4(1):83-9. PubMed ID: 3872727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Induction of beta-lactamases in Enterobacter cloacae with beta-lactam antibiotics].
    Cullmann W; Dick W
    Immun Infekt; 1984 Feb; 12(1):29-34. PubMed ID: 6335880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 7 alpha-formylamino substituent confers beta-lactamase-inactivating potency on 1-oxacephalosporins.
    Murakami K; Doi M; Yoshida T
    Antimicrob Agents Chemother; 1986 Sep; 30(3):447-52. PubMed ID: 3490828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formadicins, new monocyclic beta-lactam antibiotics of bacterial origin. I. Taxonomy, fermentation and biological activities.
    Katayama N; Nozaki Y; Okonogi K; Ono H; Harada S; Okazaki H
    J Antibiot (Tokyo); 1985 Sep; 38(9):1117-27. PubMed ID: 3934120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of beta-lactamase by various beta-lactam antibiotics in Enterobacter cloacae.
    Minami S; Yotsuji A; Inoue M; Mitsuhashi S
    Antimicrob Agents Chemother; 1980 Sep; 18(3):382-5. PubMed ID: 6968541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mechanism of enzymatic resistance to beta-lactam antibiotics].
    Philippon A; Paul G; Nevot P
    Presse Med; 1986 Dec; 15(46):2290-6. PubMed ID: 2949270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mechanisms of bacterial resistance to beta-lactams by beta-lactamases].
    Sawai T
    Nihon Rinsho; 1997 May; 55(5):1225-30. PubMed ID: 9155179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo antibacterial activities of carumonam (AMA-1080), a new N-sulfonated monocyclic beta-lactam antibiotic.
    Imada A; Kondo M; Okonogi K; Yukishige K; Kuno M
    Antimicrob Agents Chemother; 1985 May; 27(5):821-7. PubMed ID: 3874598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Energetic, structural, and antimicrobial analyses of beta-lactam side chain recognition by beta-lactamases.
    Caselli E; Powers RA; Blasczcak LC; Wu CY; Prati F; Shoichet BK
    Chem Biol; 2001 Jan; 8(1):17-31. PubMed ID: 11182316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the 7 alpha-methoxy and side-chain carboxyl of moxalactam in beta-lactamase stability and antibacterial activity.
    Murakami K; Yoshida T
    Antimicrob Agents Chemother; 1981 Jan; 19(1):1-7. PubMed ID: 6454378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cephabacins, new cephem antibiotics of bacterial origin. IV. Antibacterial activities, stability to beta-lactamases and mode of action.
    Nozaki Y; Okonogi K; Katayama N; Ono H; Harada S; Kondo M; Okazaki H
    J Antibiot (Tokyo); 1984 Dec; 37(12):1555-65. PubMed ID: 6335505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ability of newer beta-lactam antibiotics to induce beta-lactamase production in Enterobacter cloacae.
    Then RL
    Eur J Clin Microbiol; 1987 Aug; 6(4):451-5. PubMed ID: 3499315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical and laboratory significance of inducible beta-lactamases].
    Bedenić B; Zagar Z
    Lijec Vjesn; 1995; 117(9-10):249-53. PubMed ID: 8643019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vitro activity of Sch 34343 against Gram-negative bacteria producing characterized beta-lactamases.
    Dornbusch K; Frolander F; Cacciapuoti AF; Naples L; Hare RS; Miller GH
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():85-97. PubMed ID: 3897175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors that influence the evolution of beta-lactam resistance in beta-lactamase-inducible strains of Enterobacter cloacae and Pseudomonas aeruginosa.
    Aronoff SC; Shlaes DM
    J Infect Dis; 1987 May; 155(5):936-41. PubMed ID: 3104483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance caused by decreased penetration of beta-lactam antibiotics into Enterobacter cloacae.
    Bush K; Tanaka SK; Bonner DP; Sykes RB
    Antimicrob Agents Chemother; 1985 Apr; 27(4):555-60. PubMed ID: 3873900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibacterial and β-Lactamase Inhibitory Activity of Monocyclic β-Lactams.
    Decuyper L; Jukič M; Sosič I; Žula A; D'hooghe M; Gobec S
    Med Res Rev; 2018 Mar; 38(2):426-503. PubMed ID: 28815732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.